Reply to Boyd et al
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
---|---|
Enthalten in: |
Clinical infectious diseases - 60(2015), 2, Seite 327 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Solomon, Marc M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-HIV Agents - administration & dosage |
---|
doi: |
10.1093/cid/ciu814 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1956624589 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1956624589 | ||
003 | DE-627 | ||
005 | 20230714141556.0 | ||
007 | tu | ||
008 | 160206s2015 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1093/cid/ciu814 |2 doi | |
028 | 5 | 2 | |a PQ20160617 |
035 | |a (DE-627)OLC1956624589 | ||
035 | |a (DE-599)GBVOLC1956624589 | ||
035 | |a (PRQ)c828-544914207ee22618689fc5803cf89082261436e590dae376d92ab7de8546df510 | ||
035 | |a (KEY)0124598820150000060000200327replytoboydetal | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DE-600 |
100 | 1 | |a Solomon, Marc M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Reply to Boyd et al |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
650 | 4 | |a Pre-Exposure Prophylaxis - methods | |
650 | 4 | |a HIV Infections - transmission | |
650 | 4 | |a Syphilis - transmission | |
650 | 4 | |a Anti-HIV Agents - administration & dosage | |
650 | 4 | |a HIV Infections - complications | |
650 | 4 | |a Syphilis - complications | |
700 | 1 | |a Mayer, Kenneth H |4 oth | |
700 | 1 | |a Glidden, David V |4 oth | |
700 | 1 | |a Guanira, Juan V |4 oth | |
700 | 1 | |a Grant, Robert M |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases |d Cary, NC : Oxford Univ. Press, 1992 |g 60(2015), 2, Seite 327 |w (DE-627)131041878 |w (DE-600)1099781-7 |w (DE-576)028046099 |x 1058-4838 |7 nnns |
773 | 1 | 8 | |g volume:60 |g year:2015 |g number:2 |g pages:327 |
856 | 4 | 1 | |u http://dx.doi.org/10.1093/cid/ciu814 |3 Volltext |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25323702 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_168 | ||
912 | |a GBV_ILN_183 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4219 | ||
951 | |a AR | ||
952 | |d 60 |j 2015 |e 2 |h 327 |